Roivant decants another Vant armed with Eisai blood cancer drug and plans to start phase...

cafead

Administrator
Staff member
  • cafead   Feb 14, 2022 at 12:12: PM
via Roivant Sciences has spawned another Vant. The latest addition to the clan is Hemavant, a biotech that starts life with a former Eisai drug and plans to start a study in patients with myelodysplastic syndromes (MDS) this year.

article source